ID   FOLR2_HUMAN             Reviewed;         255 AA.
AC   P14207; Q05CA5; Q6GTE8;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 4.
DT   10-MAY-2017, entry version 152.
DE   RecName: Full=Folate receptor beta;
DE            Short=FR-beta;
DE   AltName: Full=Folate receptor 2;
DE   AltName: Full=Folate receptor, fetal/placental;
DE   AltName: Full=Placental folate-binding protein;
DE            Short=FBP;
DE   Flags: Precursor;
GN   Name=FOLR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=8445646; DOI=10.1006/jmbi.1993.1116;
RA   Page S.T., Owen W.C., Price K., Elwood P.C.;
RT   "Expression of the human placental folate receptor transcript is
RT   regulated in human tissues. Organization and full nucleotide sequence
RT   of the gene.";
RL   J. Mol. Biol. 229:1175-1183(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, TISSUE
RP   SPECIFICITY, GLYCOSYLATION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Placenta;
RX   PubMed=2605182; DOI=10.1021/bi00446a042;
RA   Ratnam M., Marquardt H., Duhring J.L., Freisheim J.H.;
RT   "Homologous membrane folate binding proteins in human placenta:
RT   cloning and sequence of a cDNA.";
RL   Biochemistry 28:8249-8254(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8106441;
RA   Sadasivan E., Cedeno M.M., Rothenberg S.P.;
RT   "Characterization of the gene encoding a folate-binding protein
RT   expressed in human placenta. Identification of promoter activity in a
RT   G-rich SP1 site linked with the tandemly repeated GGAAG motif for the
RT   ets encoded GA-binding protein.";
RL   J. Biol. Chem. 269:4725-4735(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 68-86; 102-120 AND 173-184.
RX   PubMed=2561247; DOI=10.1016/0065-2571(89)90091-5;
RA   Freisheim J.H., Price E.M., Ratnam M.;
RT   "Folate coenzyme and antifolate transport proteins in normal and
RT   neoplastic cells.";
RL   Adv. Enzyme Regul. 29:13-26(1989).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=4066659;
RA   Antony A.C., Kane M.A., Portillo R.M., Elwood P.C., Kolhouse J.F.;
RT   "Studies of the role of a particulate folate-binding protein in the
RT   uptake of 5-methyltetrahydrofolate by cultured human KB cells.";
RL   J. Biol. Chem. 260:14911-14917(1985).
RN   [8]
RP   GPI-ANCHOR AT ASN-230.
RX   PubMed=7578066; DOI=10.1021/bi00044a039;
RA   Yan W., Ratnam M.;
RT   "Preferred sites of glycosylphosphatidylinositol modification in
RT   folate receptors and constraints in the primary structure of the
RT   hydrophobic portion of the signal.";
RL   Biochemistry 34:14594-14600(1995).
RN   [9]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=9398177; DOI=10.1021/bi970845w;
RA   Wang J., Shen F., Yan W., Wu M., Ratnam M.;
RT   "Proteolysis of the carboxyl-terminal GPI signal independent of GPI
RT   modification as a mechanism for selective protein secretion.";
RL   Biochemistry 36:14583-14592(1997).
RN   [10]
RP   INDUCTION BY RETINOIC ACID.
RX   PubMed=20632143; DOI=10.1007/s13277-010-0074-0;
RA   Xu Y., Wang T., Tang R., Tang S.;
RT   "All-trans retinoic acid is capable of inducing folate receptor beta
RT   expression in KG-1 cells.";
RL   Tumor Biol. 31:589-595(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 24-228 IN COMPLEXES WITH
RP   FOLATE AND THE ANTIFOLATES METHOTREXATE; AMINOPTERIN AND PEMETREXED,
RP   FUNCTION, GLYCOSYLATION AT ASN-195, AND DISULFIDE BONDS.
RX   PubMed=23934049; DOI=10.1073/pnas.1308827110;
RA   Wibowo A.S., Singh M., Reeder K.M., Carter J.J., Kovach A.R., Meng W.,
RA   Ratnam M., Zhang F., Dann C.E. III;
RT   "Structures of human folate receptors reveal biological trafficking
RT   states and diversity in folate and antifolate recognition.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:15180-15188(2013).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-236.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Binds to folate and reduced folic acid derivatives and
CC       mediates delivery of 5-methyltetrahydrofolate and folate analogs
CC       into the interior of cells. Has high affinity for folate and folic
CC       acid analogs at neutral pH. Exposure to slightly acidic pH after
CC       receptor endocytosis triggers a conformation change that strongly
CC       reduces its affinity for folates and mediates their release.
CC       {ECO:0000269|PubMed:23934049, ECO:0000269|PubMed:2605182,
CC       ECO:0000269|PubMed:4066659}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor.
CC       Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in placenta and hematopoietic cells.
CC       Expression is increased in malignant tissues.
CC       {ECO:0000269|PubMed:2605182, ECO:0000269|PubMed:8445646}.
CC   -!- INDUCTION: Up-regulated by retinoic acid.
CC       {ECO:0000269|PubMed:20632143}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:23934049,
CC       ECO:0000269|PubMed:2605182}.
CC   -!- SIMILARITY: Belongs to the folate receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X69516; CAA49267.1; -; Genomic_DNA.
DR   EMBL; J02876; AAA35821.1; -; mRNA.
DR   EMBL; U02714; AAA17370.1; -; Genomic_DNA.
DR   EMBL; U02716; AAA17370.1; JOINED; Genomic_DNA.
DR   EMBL; AK222643; BAD96363.1; -; mRNA.
DR   EMBL; BC058036; AAH58036.1; -; mRNA.
DR   EMBL; BC027894; AAH27894.1; -; mRNA.
DR   CCDS; CCDS8212.1; -.
DR   PIR; A53315; A33417.
DR   RefSeq; NP_000794.3; NM_000803.4.
DR   RefSeq; NP_001107006.1; NM_001113534.1.
DR   RefSeq; NP_001107007.1; NM_001113535.1.
DR   RefSeq; NP_001107008.1; NM_001113536.1.
DR   UniGene; Hs.433159; -.
DR   PDB; 4KMY; X-ray; 1.80 A; A=24-228.
DR   PDB; 4KMZ; X-ray; 2.30 A; A=24-228.
DR   PDB; 4KN0; X-ray; 2.10 A; A=24-228.
DR   PDB; 4KN1; X-ray; 2.30 A; A=24-228.
DR   PDB; 4KN2; X-ray; 2.60 A; A/B/C=24-227.
DR   PDBsum; 4KMY; -.
DR   PDBsum; 4KMZ; -.
DR   PDBsum; 4KN0; -.
DR   PDBsum; 4KN1; -.
DR   PDBsum; 4KN2; -.
DR   ProteinModelPortal; P14207; -.
DR   SMR; P14207; -.
DR   STRING; 9606.ENSP00000298223; -.
DR   BindingDB; P14207; -.
DR   ChEMBL; CHEMBL5064; -.
DR   DrugBank; DB05168; EC145.
DR   DrugBank; DB00158; Folic Acid.
DR   BioMuta; FOLR2; -.
DR   DMDM; 116241366; -.
DR   PaxDb; P14207; -.
DR   PeptideAtlas; P14207; -.
DR   PRIDE; P14207; -.
DR   DNASU; 2350; -.
DR   Ensembl; ENST00000298223; ENSP00000298223; ENSG00000165457.
DR   GeneID; 2350; -.
DR   KEGG; hsa:2350; -.
DR   UCSC; uc001ose.5; human.
DR   CTD; 2350; -.
DR   DisGeNET; 2350; -.
DR   GeneCards; FOLR2; -.
DR   HGNC; HGNC:3793; FOLR2.
DR   MIM; 136425; gene.
DR   neXtProt; NX_P14207; -.
DR   OpenTargets; ENSG00000165457; -.
DR   PharmGKB; PA28209; -.
DR   eggNOG; ENOG410IFFP; Eukaryota.
DR   eggNOG; ENOG4111IU4; LUCA.
DR   GeneTree; ENSGT00390000010470; -.
DR   HOGENOM; HOG000006539; -.
DR   HOVERGEN; HBG039612; -.
DR   InParanoid; P14207; -.
DR   KO; K13649; -.
DR   OMA; PVALCEG; -.
DR   OrthoDB; EOG091G0GIA; -.
DR   PhylomeDB; P14207; -.
DR   TreeFam; TF328532; -.
DR   Reactome; R-HSA-163125; Post-translational modification: synthesis of GPI-anchored proteins.
DR   Reactome; R-HSA-196757; Metabolism of folate and pterines.
DR   GeneWiki; FOLR2; -.
DR   GenomeRNAi; 2350; -.
DR   PRO; PR:P14207; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000165457; -.
DR   CleanEx; HS_FOLR2; -.
DR   ExpressionAtlas; P14207; baseline and differential.
DR   Genevisible; P14207; HS.
DR   GO; GO:0031362; C:anchored component of external side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008144; F:drug binding; IPI:BHF-UCL.
DR   GO; GO:0005542; F:folic acid binding; IDA:UniProtKB.
DR   GO; GO:0061714; F:folic acid receptor activity; IC:BHF-UCL.
DR   GO; GO:0008517; F:folic acid transporter activity; IDA:UniProtKB.
DR   GO; GO:0051870; F:methotrexate binding; IDA:BHF-UCL.
DR   GO; GO:0006501; P:C-terminal protein lipidation; TAS:Reactome.
DR   GO; GO:0046655; P:folic acid metabolic process; TAS:Reactome.
DR   GO; GO:0015884; P:folic acid transport; IDA:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; NAS:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IC:BHF-UCL.
DR   GO; GO:0050758; P:regulation of thymidylate synthase biosynthetic process; IC:BHF-UCL.
DR   InterPro; IPR004269; Folate_rcpt.
DR   InterPro; IPR018143; Folate_rcpt-like.
DR   InterPro; IPR032937; FOLR2.
DR   PANTHER; PTHR10517; PTHR10517; 1.
DR   PANTHER; PTHR10517:SF24; PTHR10517:SF24; 1.
DR   Pfam; PF03024; Folate_rec; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Folate-binding;
KW   Glycoprotein; GPI-anchor; Lipoprotein; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Secreted; Signal; Transport.
FT   SIGNAL        1     16
FT   CHAIN        17    230       Folate receptor beta.
FT                                /FTId=PRO_0000008806.
FT   PROPEP      231    255       Removed in mature form.
FT                                /FTId=PRO_0000008807.
FT   REGION      118    122       Folate binding. {ECO:0000244|PDB:4KMZ}.
FT   REGION      151    156       Folate binding. {ECO:0000244|PDB:4KMZ}.
FT   BINDING      97     97       Folate. {ECO:0000244|PDB:4KMZ}.
FT   BINDING     101    101       Folate. {ECO:0000244|PDB:4KMZ}.
FT   BINDING     190    190       Folate. {ECO:0000244|PDB:4KMZ}.
FT   LIPID       230    230       GPI-anchor amidated asparagine.
FT                                {ECO:0000269|PubMed:7578066}.
FT   CARBOHYD    115    115       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4KN0}.
FT   CARBOHYD    195    195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4KMZ,
FT                                ECO:0000244|PDB:4KN0,
FT                                ECO:0000244|PDB:4KN1,
FT                                ECO:0000244|PDB:4KN2,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     31     59       {ECO:0000244|PDB:4KMY,
FT                                ECO:0000244|PDB:4KMZ,
FT                                ECO:0000244|PDB:4KN0,
FT                                ECO:0000244|PDB:4KN1,
FT                                ECO:0000244|PDB:4KN2,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     51     99       {ECO:0000244|PDB:4KMY,
FT                                ECO:0000244|PDB:4KMZ,
FT                                ECO:0000244|PDB:4KN0,
FT                                ECO:0000244|PDB:4KN1,
FT                                ECO:0000244|PDB:4KN2,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     60    103       {ECO:0000244|PDB:4KMY,
FT                                ECO:0000244|PDB:4KMZ,
FT                                ECO:0000244|PDB:4KN0,
FT                                ECO:0000244|PDB:4KN1,
FT                                ECO:0000244|PDB:4KN2,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     83    169       {ECO:0000244|PDB:4KMY,
FT                                ECO:0000244|PDB:4KMZ,
FT                                ECO:0000244|PDB:4KN0,
FT                                ECO:0000244|PDB:4KN1,
FT                                ECO:0000244|PDB:4KN2,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     90    140       {ECO:0000244|PDB:4KMY,
FT                                ECO:0000244|PDB:4KMZ,
FT                                ECO:0000244|PDB:4KN0,
FT                                ECO:0000244|PDB:4KN1,
FT                                ECO:0000244|PDB:4KN2,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID    129    203       {ECO:0000244|PDB:4KMY,
FT                                ECO:0000244|PDB:4KMZ,
FT                                ECO:0000244|PDB:4KN0,
FT                                ECO:0000244|PDB:4KN1,
FT                                ECO:0000244|PDB:4KN2,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID    133    183       {ECO:0000244|PDB:4KMY,
FT                                ECO:0000244|PDB:4KMZ,
FT                                ECO:0000244|PDB:4KN0,
FT                                ECO:0000244|PDB:4KN1,
FT                                ECO:0000244|PDB:4KN2,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID    146    163       {ECO:0000244|PDB:4KMY,
FT                                ECO:0000244|PDB:4KMZ,
FT                                ECO:0000244|PDB:4KN0,
FT                                ECO:0000244|PDB:4KN1,
FT                                ECO:0000244|PDB:4KN2,
FT                                ECO:0000269|PubMed:23934049}.
FT   VARIANT     236    236       H -> N (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036408.
FT   CONFLICT    103    103       C -> V (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    111    112       IQ -> VR (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    115    115       N -> D (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    117    117       S -> T (in Ref. 2; AAA35821, 3; AAA17370
FT                                and 6; AA sequence). {ECO:0000305}.
FT   CONFLICT    141    141       H -> L (in Ref. 3; AAA17370).
FT                                {ECO:0000305}.
FT   CONFLICT    244    244       S -> R (in Ref. 3; AAA17370).
FT                                {ECO:0000305}.
FT   HELIX        24     27       {ECO:0000244|PDB:4KMY}.
FT   STRAND       33     36       {ECO:0000244|PDB:4KMZ}.
FT   HELIX        49     54       {ECO:0000244|PDB:4KMY}.
FT   STRAND       57     60       {ECO:0000244|PDB:4KMY}.
FT   HELIX        62     68       {ECO:0000244|PDB:4KMY}.
FT   STRAND       74     76       {ECO:0000244|PDB:4KMY}.
FT   TURN         80     83       {ECO:0000244|PDB:4KMY}.
FT   HELIX        88    103       {ECO:0000244|PDB:4KMY}.
FT   HELIX       108    110       {ECO:0000244|PDB:4KMY}.
FT   STRAND      111    116       {ECO:0000244|PDB:4KMY}.
FT   STRAND      119    123       {ECO:0000244|PDB:4KMY}.
FT   STRAND      126    128       {ECO:0000244|PDB:4KN0}.
FT   HELIX       130    140       {ECO:0000244|PDB:4KMY}.
FT   STRAND      144    146       {ECO:0000244|PDB:4KMY}.
FT   STRAND      150    152       {ECO:0000244|PDB:4KN0}.
FT   HELIX       172    175       {ECO:0000244|PDB:4KMY}.
FT   HELIX       179    185       {ECO:0000244|PDB:4KMY}.
FT   TURN        186    188       {ECO:0000244|PDB:4KMY}.
FT   STRAND      189    191       {ECO:0000244|PDB:4KMY}.
FT   STRAND      200    204       {ECO:0000244|PDB:4KMY}.
FT   HELIX       216    223       {ECO:0000244|PDB:4KMY}.
SQ   SEQUENCE   255 AA;  29280 MW;  F585715CF5631C98 CRC64;
     MVWKWMPLLL LLVCVATMCS AQDRTDLLNV CMDAKHHKTK PGPEDKLHDQ CSPWKKNACC
     TASTSQELHK DTSRLYNFNW DHCGKMEPAC KRHFIQDTCL YECSPNLGPW IQQVNQSWRK
     ERFLDVPLCK EDCQRWWEDC HTSHTCKSNW HRGWDWTSGV NKCPAGALCR TFESYFPTPA
     ALCEGLWSHS YKVSNYSRGS GRCIQMWFDS AQGNPNEEVA RFYAAAMHVN AGEMLHGTGG
     LLLSLALMLQ LWLLG
//
